title: Effects of pentoxifylline during Schistosoma mansoni infection in Swiss mice: an analysis of worm burden, fecundity and liver histopathology.
abstract: The short-term effects of pentoxifylline (PTX) on granulomatous lesions during Schistosoma mansoni infection in Swiss mice were evaluated. Drug administration was initiated 42 and 140 days post-infection (DPI) for the acute and chronic infection groups, respectively. Treatment was carried out daily with 200 mg/kg (subcutaneous route) of the drug for five consecutive days. Recovery of parasites and tissues was performed at 49 DPI and 147 DPI, respectively. Liver histological analysis showed a decrease in the inflammatory reaction and fibrous content of the granulomas studied, and a significant reduction (P < 0.001) in their mean diameter was observed in the groups of rodents treated with PTX in acute and chronic infection, when compared to their respective control groups. However, no alteration in the number of S. mansoni recovered from the portal system was observed, and egg-laying kinetics was not notably modified by PTX treatment, and the immature stage distribution of S. mansoni eggs showed minor intrinsic variations with no statistical differences in the parameter second-stage/female/g among untreated mice and treated mice in acute and chronic infections, respectively, when evaluated by intestinal oograms. Data obtained indicate probable immunomodulatory effects of PTX in murine schistosomiasis both in acute and chronic infection.
authors.affiliation: Laboratório de Taxonomia e Biologia de Invertebrados, Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
authors.forename: V L T
authors.initials: VL
authors.lastname: Mati
authors.forename: R M C
authors.initials: RM
authors.lastname: Freitas
authors.forename: A L
authors.initials: AL
authors.lastname: Melo
mesh_terms: D000208:Acute Disease; D000818:Animals; D002908:Chronic Disease; D005260:Female; D005298:Fertility / Q000187:drug effects; D006099:Granuloma / Q000188:drug therapy / Q000276:immunology / Q000469:parasitology / Q000473:pathology; D008099:Liver / Q000469:parasitology / Q000473:pathology*; D008297:Male; D051379:Mice; D010270:Parasite Egg Count; D010431:Pentoxifylline / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D011168:Portal System / Q000469:parasitology; D012550:Schistosoma mansoni / Q000187:drug effects* / Q000302:isolation & purification / Q000502:physiology*; D012555:Schistosomiasis mansoni / Q000188:drug therapy* / Q000276:immunology / Q000469:parasitology / Q000473:pathology; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D010431:Pentoxifylline